The University of California, San Diego (UCSD) has initiated a clinical trial to assess Nexalin Technology's Halo Clarity ...
For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
Hosted on MSN2d
FDA Takes Action on Allergies, Diabetes, Parkinson’s, and Deadly Food Safety Scare—What You Need to KnowThe U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements ...
Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas, ...
For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback